期刊文献+

血清HA,PCⅢ,Ⅳ-C,LN联合PLD检测对肝硬化诊断价值的探讨 被引量:3

Study on the diagnostic value of serum hyaluronic acid,precollagen type Ⅲ,HA,colagen type Ⅳ,laminin and procollagen type Ⅲ concentrations for liver cirrhosis
下载PDF
导出
摘要 目的:探讨透明质酸、型前胶原、型胶原、层黏连蛋白和脯氨酸肽酶对肝硬化的诊断价值。方法:采用放射免疫分析法和微量法对84例肝硬化患者血清中上述五项指标的代谢变化进行观察,并对结果进行分析。结果:与正常人相比,肝硬化和肝硬化腹水患者血清透明质酸、型前胶原、型胶原、层黏连蛋白和脯氨酸肽酶水平明显增高(P<0.01),脯氨酸肽酶与透明质酸、型前胶原、型胶原、层黏连蛋白之间有相关性。结论:血清透明质酸、型前胶原、型胶原、层黏连蛋白和脯氨酸肽酶等指标均能较好地反映肝纤维化的活动水平及程度。 Objective To investigate the diagnostic value of serum levels of hyaluronic acid, precollagen type Ⅲ , colagen type Ⅳ ,laminin and prolidase for liver cirrhosis. Methods Serum levels of colyentype Ⅳ ,precollagen type Ⅲ ,hyaluronic acid,laminin and prolidase were measured with radioimmunity analysis and micromethod in 20 controls and 84 patients with liver cirrhosis. Results Serum levels of hyaluronic acid,precollagen type Ⅲ ,colagen type Ⅳ ,laminin and prolidase were significantly higher in patients with liver cirrhosis than those in controls (P〈0. 01). Serum level of prodidase was positively correlated with hypaluronic acid, precollagen type, Ⅲ, collagen type to and laminin. Conclusion Serum levels of these markers can reflect the degree of hepatic fibrosis and severity of liver damage.
出处 《实用诊断与治疗杂志》 2005年第8期547-548,共2页 Journal of Practical Diagnosis and Therapy
基金 湖南省教育厅资助课题(编号:96156)
关键词 肝硬化 透明质酸 Ⅲ型前胶原 Ⅳ型胶原 层黏连蛋白 脯氨酸肽酶 Liver cirrosis hyaluronic acid precollagen type Ⅲ collagen type Ⅳ laminin prolidase
  • 相关文献

参考文献6

二级参考文献15

共引文献132

同被引文献26

  • 1朱康顺,单鸿,李征然,沈新颖,孟晓春,关守海,姜在波,黄明声.部分性脾栓塞术治疗肝硬化脾功能亢进的远期疗效观察[J].中华放射学杂志,2004,38(7):732-736. 被引量:70
  • 2翟士军,王建国,刘瑞华,权敏.慢性肝病患者血清HA,LN,PCⅢ,Ⅳ-CRIA及临床意义[J].放射免疫学杂志,2004,17(5):379-380. 被引量:1
  • 3潘继承,朱建一,吕志刚,孙宏伟.Ⅲ型前胶原、Ⅳ型胶原、透明质酸及层粘连蛋白在诊断肝纤维化中的意义[J].临床检验杂志,2005,23(2):143-144. 被引量:19
  • 4黄筵庭.门静脉高压症外科学[M].北京:人民卫生出版社,2002.355-383.
  • 5朱建新,侯淑琴,李彦豪.肝胆疾病介入治疗技术[M].广州:广东科技出版社,1996:144
  • 6Noguchi H, Hirai K, Aoki Y, et al. Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism[J]. Hepatology, 1995,22(6) : 1682
  • 7Sakata K, Hirai K, Tanikawa K. A long-term investigation of transcatheter splenic arterial embolization for hypersplenism[J].Hepat ogast roenteroiogy, 1996,43 (7) : 309
  • 8Tajiri T, Onda M, Yoshida H, et al. Long-term hematological and biochemical effects of partial splenic embolization in hepatic cirrhosis[J]. Hepatogastroenteroiogy, 2002,49 (47) : 1445
  • 9Murata K, Shiraki K, Takase K, et al. Long-term follow-up for patients with liver cirrhosis after partial splenic embolization[J].Hepatogastroenteroiogy, 1996,43(11 ) : 1212
  • 10Numata S, Akagi K, Sakino I, et el. Partial splenic embolization for the treatment of liver cirrhosis with hypersplenism:assessment of clinical response and lixer function[J]. Nippon Shokakibyo Gakkai Zasshi (Japanese), 1997,94 (2) : 526

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部